-
Experimental targeted therapy shows promise for histiocytosis, a rare blood cancer
The first time Joey Carlsen Martinez came to Memorial Sloan Kettering Cancer Center (MSK), he was in terrible shape. He... Read more -
New drug study shows improved survival for early breast cancer
Mayo Clinic researchers collaborated on a new study led by Eli Lilly showing that the drug abemaciclib improves survival for... Read more -
Antidepressants show promise for alleviating jaw pain
Certain antidepressants can help alleviate chronic jaw pain caused by temporomandibular disorders (TMDs), according to a research review by a... Read more -
Parent opioid prescriptions linked to teen and young adult opioid use
If a parent has persistent opioid prescriptions, their adolescent or young adult offspring has more than double the risk of... Read more -
Novel drug combinations pave the way for personalized leukemia therapies
Researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), have published a review on... Read more -
Amid the noise about Tylenol, there's a real risk—an overdose
While news feeds and social media are abuzz with unproven claims about links between acetaminophen and autism in children, there... Read more -
Psilocybin + mindfulness show promise for health care worker depression
Front-line health care workers struggling with depression after the COVID-19 pandemic experienced significant relief from a treatment combining psilocybin group... Read more -
Cancer drug quality in Africa is a worry, four-country study finds
The number of people receiving treatment for cancer has risen dramatically in the last decade in many African countries. For... Read more -
No benefit from ketamine for patients hospitalized with depression, clinical trial reports
Findings from a randomized and blinded clinical trial investigating repeated ketamine infusions for treating depression have revealed no extra benefit... Read more -
Stopping long-term opioid treatment unlikely to increase suicide risk, major study finds
People on long-term opioid treatment can be reassured that stopping these medicines is not likely to increase their risk of... Read more -
Antidepressants vary widely in their physical side effects, highlighting the need for personalized prescribing
Antidepressants can differ widely in how they physically affect the body, including around a 4 kg difference in weight change... Read more -
FDA to fast-track nine experimental drugs under new Trump program
The U.S. Food and Drug Administration (FDA) announced that it will fast-track review of nine experimental drugs.... Read more -
Mortality down with GLP-1 receptor agonist use in T2D, especially in those with OSA
Patients with type 2 diabetes mellitus (T2DM) prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have significantly lower one-year mortality, especially... Read more -
SGLT2 inhibitors may slow nodule growth in pulmonary malignancies
For patients with diabetes and early-stage pulmonary malignancies, administration of a sodium-glucose cotransporter 2 inhibitor (SGLT2-i) slows nodule growth and... Read more -
Nearly half of Finns with chronic conditions find medication therapy a burden, study finds
According to a recent study, 44% of people with chronic conditions who responded to a population-based survey experienced medication-related burden... Read more
